C4X Discovery Holdings PLC Notice of Results (3269W)
22 Abril 2021 - 5:31AM
UK Regulatory
TIDMC4XD
RNS Number : 3269W
C4X Discovery Holdings PLC
22 April 2021
C4X Discovery Holdings plc
("C4XD", "C4X Discovery" or the "Company")
Notice of Results
22 April 2021 - C4X Discovery Holdings plc (AIM: C4XD), a
pioneering Drug Discovery company, will be announcing its interim
results for the six months ended 31 January 2021 on Thursday 29
April 2021.
- ENDS -
Contacts
C4X Discovery Holdings
Mo Noonan, Communications +44 (0)787 6444977
Panmure Gordon (UK) Limited (NOMAD and Broker)
Freddy Crossley, Emma Earl (Corporate Finance) +44 (0)20 7886 2500
Rupert Dearden (Corporate Broking)
C4X Discovery Media - Consilium Strategic Communications
Mary-Jane Elliott, Chris Gardner, Matthew Neal +44 (0)203 709 5700
Notes to Editors:
About C4X Discovery
C4X Discovery ("C4XD") is a pioneering Drug Discovery company
combining scientific expertise with cutting-edge Drug Discovery
technologies to efficiently deliver world leading medicines, which
are developed by our partners for the benefit of patients. We have
a highly valuable and differentiated approach to Drug Discovery
through our enhanced DNA-based target identification and candidate
molecule design capabilities, generating small molecule drug
candidates across multiple disease areas including inflammation,
neurodegeneration, oncology and addictive disorders. Our
commercially attractive portfolio ranges from early stage novel
target opportunities to late stage Drug Discovery programmes ready
for out-licensing to partners and we have two commercially
partnered programmes with one candidate in clinical
development.
We collaborate with leading pharmaceutical and life sciences
companies to enrich our expertise and take our assets through
pre-clinical and clinical development. Through early-stage
revenue-generating licensing deals, we realise returns from our
high value pre-clinical assets which are reinvested to maximise the
value of our Drug Discovery portfolio. For more information visit
us at www.c4xdiscovery.com or follow us on twitter
@C4XDiscovery.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORITMMTMTJTBMB
(END) Dow Jones Newswires
April 22, 2021 06:31 ET (10:31 GMT)
C4x Discovery (LSE:C4XD)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
C4x Discovery (LSE:C4XD)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024